[Therapeutic measures in bradycardia].
D001285:Atropine / Q000627:therapeutic use; D001919:Bradycardia / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy*; D002346:Carotid Sinus; D006333:Heart Failure / Q000150:complications; D006801:Humans; D009921:Metaproterenol / Q000008:administration & dosage / Q000627:therapeutic use; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications; D009205:Myocarditis / Q000150:complications; D010138:Pacemaker, Artificial; D013610:Tachycardia / Q000150:complications; D013963:Thyroid Hormones / Q000627:therapeutic use
D013963:Thyroid Hormones; D009921:Metaproterenol; D001285:Atropine
Therapeutisches Vorgehen bei Bradykardie